University of Patras is a public university in Patras, Greece. It is the third largest university in Greece with respect to the size of the student body, the staff, and the number of departments.

During the past decade, University of Patras conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Patras" #1 sponsor was "Celgene" with 4 trials, followed by "Azienda Ospedaliero-Universitaria Careggi" with 1 trials sponsored, "Hôpital Armand Trousseau" with 1 trials sponsored, "J.J.Swen" with 1 trials sponsored and "M.A. Med Alliance S.A." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Patras" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Andaluz Health Service" with 1 trials as a collaborator, "Bio.Logis Genetic Information Management" with 1 trials as a collaborator, "Centro di Riferimento Oncologico - Aviano" with 1 trials as a collaborator and "Federal Institute for Drugs and Medical Devices" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "University of Patras" are "AV Fistula" (1 trials), "Adverse Drug Reaction" (1 trials), "Analgesia" (1 trials), "Intesive Care" (1 trials) and "Intratracheal Ventilation" (1 trials). Many other conditions were trialed in "University of Patras" in a lesser frequency.

Most popular intervention types in "University of Patras" are "Drug" (4 trials), "Other" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials), "Ablation therapy (AT)" (1 trials), "Active Surveillance (AS)" (1 trials), "Best Supportiv Care (BSC)" (1 trials) and "Control Arm" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Patras" are 8 trials for "All" genders.

Currently, there are NaN active trials in "University of Patras". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Patras, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Patras, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".